Related Experiment Video

Updated: May 23, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Reversing the myths obstructing the determination of optimal age- and disease-based drug dosing in pediatrics

Michael D Reed1

  • 1The Rebecca D. Considine Research Institute, Division of Clinical Pharmacology and Toxicology, and Department of Pediatrics, Children's Hospital Medical Center of Akron, Akron, Ohio.

The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|April 6, 2012
PubMed

Insights

Pediatric clinical pharmacology research is crucial for safe and effective drug dosing across all ages. Advances in research methods are improving drug therapy for children, moving beyond outdated "therapeutic orphan" myths.

Area of Science:

  • Pediatric clinical pharmacology
  • Drug efficacy and toxicity
  • Pediatric drug dosing

Background:

  • Critical clinical pharmacology research in pediatrics is essential for optimizing drug regimens.
  • The historical
  • therapeutic orphan
  • concept, though outdated, still impacts pediatric drug therapy.
  • New drug regimens demand precise dosing for efficacy and safety.

Purpose of the Study:

  • To highlight the critical need for comprehensive pediatric clinical pharmacology research.
  • To address and dispel persistent myths regarding pediatric drug dosing.
  • To emphasize the importance of leveraging modern research advancements.

Main Methods:

  • Review of advancements in clinical medicine and research methodologies.
  • Analysis of study design, sampling, and statistical techniques in pediatric pharmacology.
  • Identification and refutation of outdated myths in the field.

Main Results:

  • Modern advances have significantly improved the paradigm for pediatric clinical pharmacology research.
  • Dispelling myths can foster greater research into optimal pediatric drug therapy.
  • Enhanced research leads to improved drug efficacy and minimized toxicity in children.

Conclusions:

  • Comprehensive pediatric clinical pharmacology research is vital across the entire age spectrum.
  • Utilizing advanced research methods is key to overcoming past limitations.
  • The future of pediatric practice relies on evidence-based, optimized drug therapy.

More Related Videos

Adult and Pediatric Porcine Model of Acute Volume Overload06:09

Adult and Pediatric Porcine Model of Acute Volume Overload

Published on: January 12, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...